Boardroom Alpha
S-1 primary document
MDLN · Registration Statement (Form S-1) · Filed October 28, 2025

Medline IncS-1 exhibit

d932091dex1021.htm
EX-10.21

Exhibit 10.21

SUPPLEMENT NO. 1 dated as of July 19, 2024 (the “Supplement”), to the Security Agreement (the “Security Agreement”), dated as of October 21, 2021, among the Grantors identified therein and BANK OF AMERICA, N.A., as Collateral Agent.

A. Reference is made to the Credit Agreement dated as of October 21, 2021 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among Medline Intermediate, LP, a Delaware limited partnership (“Holdings”), Medline Borrower, LP, a Delaware limited partnership (and successor by merger to Mozart Debt Merger Sub Inc., the “Borrower”), the other Guarantors party thereto from time to time, Bank of America, N.A., as Administrative Agent, Collateral Agent, Swing Line Lender and L/C Issuer, and each lender from time to time party thereto (collectively, the “Lenders” and individually, a “Lender”).

B. Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreement and the Security Agreement.

C. The Grantors have entered into the Security Agreement in order to induce the Lenders to make Loans and the L/C Issuers to issue Letters of Credit. Section 6.12 of the Security Agreement provides that additional Restricted Subsidiaries of the Borrower may become Grantors under the Security Agreement by execution and delivery of an instrument in the form of this Supplement. The undersigned (each, a “New Grantor”) is executing this Supplement in accordance with the requirements of the Credit Agreement to become a Grantor under the Security Agreement in order to induce the Lenders to make additional Loans and the L/C Issuers to issue additional Letters of Credit and as consideration for Loans previously made and Letters of Credit previously issued.

Accordingly, the Collateral Agent and each New Grantor agree as follows:

SECTION 1. In accordance with Section 6.12 of the Security Agreement, each New Grantor by its signature below becomes a Grantor under the Security Agreement with the same force and effect as if originally named therein as a Grantor and each New Grantor hereby (a) agrees to all the terms and provisions of the Security Agreement applicable to it as a Grantor thereunder and (b) represents and warrants that the representations and warranties made by it as a Grantor thereunder are true and correct on and as of the date hereof. In furtherance of the foregoing, each New Grantor, as security for the payment and performance in full of the Secured Obligations, does hereby create and grant to the Collateral Agent, its successors and assigns, for the benefit of the Secured Parties, their successors and assigns, a security interest in and Lien on all of such New Grantor’s right, title and interest in and to the Collateral (as defined in the Security Agreement) of such New Grantor. Each reference to a “Grantor” in the Security Agreement shall be deemed to include the New Grantors. The Security Agreement is hereby incorporated herein by reference.

SECTION 2. Each New Grantor represents and warrants to the Collateral Agent and the other Secured Parties that this Supplement has been duly authorized, executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms, except as such enforceability may be limited by Debtor Relief Laws and by general principles of equity.


SECTION 3. This Supplement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Supplement shall become effective when the Collateral Agent shall have received a counterpart of this Supplement that bears the signature of each New Grantor. Delivery of an executed signature page to this Supplement by facsimile transmission or other electronic communication shall be as effective as delivery of a manually signed counterpart of this Supplement.

SECTION 4. Each New Grantor hereby represents and warrants that (a) set forth on Schedule I attached hereto is a true and correct schedule of the information required by Sections 2.02 of the Security Agreement with respect to Schedule II to the Security Agreement applicable to it, (b) set forth under its signature hereto is the true and correct legal name of such New Grantor, its jurisdiction of formation and the location of its chief executive office and (c) Schedule II attached hereto sets forth, as of the date hereof, (i) all of such New Grantor’s United States Patents constituting Article 9 Collateral, including the name of the registered owner, type, patent or application number and the expiration date (if already issued) of each such Patent owned by such New Grantor, (ii) all of such New Grantor’s United States Trademarks constituting Article 9 Collateral, including the name of the registered owner, the registration or application number and the expiration date (if already registered) of each such Trademark owned by such New Grantor and (iii) all of such New Grantor’s United States Copyrights and exclusive Copyright Licenses of United States registered copyrights granted to a Grantor constituting Article 9 Collateral, including the name of the registered owner, title and, if applicable, the registration number of each such Copyright owned by or registered copyright exclusively licensed to such New Grantor.

SECTION 5. Except as expressly supplemented hereby, the Security Agreement shall remain in full force and effect.

SECTION 6. THIS SUPPLEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

SECTION 7. If any provision of this Supplement is held to be illegal, invalid or unenforceable, the legality, validity and enforceability of the remaining provisions of this Supplement shall not be affected or impaired thereby. The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

SECTION 8. All communications and notices hereunder shall be in writing and given as provided in Section 6.01 of the Security Agreement.

SECTION 9. Each New Grantor agrees to reimburse the Collateral Agent for its reasonable out-of-pocket expenses in connection with the execution and delivery of this Supplement, including the reasonable fees, other charges and disbursements of counsel for the Collateral Agent.

[Signature pages follow.]

 

2


IN WITNESS WHEREOF, each New Grantor and the Collateral Agent have duly executed this Supplement to the Security Agreement as of the day and year first above written.

 

MEDICAL STERILIZATION HOLDINGS, LP
By: MEDICAL STERILIZATION GP, LLC
Its: General Partner
By:  

/s/ Alexander M. Liberman

  Name:   Alexander M. Liberman
  Title:   Secretary

Jurisdiction of Formation: Delaware

Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093

 

MEDICAL STERILIZATION COMPANY (NLMX), LP

 

By: MEDICAL STERILIZATION GP, LLC

Its: General Partner
By:  

/s/ Alexander M. Liberman

  Name:   Alexander M. Liberman
  Title:   Secretary

Jurisdiction of Formation: Delaware

Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093

 

MEDICAL STERILIZATION COMPANY (US), LP

 

By: MEDICAL STERILIZATION GP, LLC

Its: General Partner

By:  

/s/ Alexander M. Liberman

  Name:   Alexander M. Liberman
  Title:   Secretary

Jurisdiction of Formation: Delaware

Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093


MEDLINE DME, LP

By: MEDLINE DME GP, LLC

Its: General Partner

By:  

/s/ James Boyle

  Name:   James Boyle
  Title:   Manager
By:  

/s/ Bradley Mariam

  Name:   Bradley Mariam
  Title:   Manager

Jurisdiction of Formation: Delaware

Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093

 

MEDLINE DME TN, LP

 

By: MEDLINE DME GP, LLC

Its: General Partner

By:  

/s/ James Boyle

  Name:   James Boyle
  Title:   Manager
By:  

/s/ Bradley Mariam

  Name:   Bradley Mariam
  Title:   Manager

Jurisdiction of Formation: Delaware

Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093


MEDLINE INTERNATIONAL TWO, LLC

By: MEDLINE INDUSTRIES, LP

Its: Manager

By: MOZART GP, LLC

Its: General Partner

By:  

/s/ Alexander M. Liberman

  Name:   Alexander M. Liberman
  Title:   Chief Legal Officer and Secretary

Jurisdiction of Formation: Illinois

Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093

 

PREFCONNECT, LLC

 

By: MEDLINE INDUSTRIES, LP

Its: Manager

By: MOZART GP, LLC

Its: General Partner

By:  

/s/ Alexander M. Liberman

  Name:   Alexander M. Liberman
  Title:   Chief Legal Officer and Secretary

Jurisdiction of Formation: Texas

Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093

 

UNITED MEDCO, LLC

By:  

/s/ Bradley Mariam

  Name:   Bradley Mariam
  Title:   President

 

Jurisdiction of Formation: Florida

Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093

 

TCS NUEVO LAREDO, LLC

By:  

/s/ Alexander M. Liberman

  Name:   Alexander M. Liberman
  Title:   Secretary

Jurisdiction of Formation: Delaware

Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093


RCI HUDSON MEXICO HOLDINGS, LLC
By: STELLAR HOLDCO, LLC
Its: Manager
By:  

/s/ Alexander M. Liberman

  Name:   Alexander M. Liberman
  Title:   President, Manager
Jurisdiction of Formation: Illinois
Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093
MRE PROPCO, LP
By: MRE GP, LLC
Its: General Partner
By:  

/s/ Alexander M. Liberman

  Name:   Alexander M. Liberman
  Title:   Chief Legal Officer and Secretary
Jurisdiction of Formation: Delaware
Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093
MRE GP, LLC
By:  

/s/ Alexander M. Liberman

  Name:   Alexander M. Liberman
  Title:   Chief Legal Officer and Secretary
Jurisdiction of Formation: Delaware
Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093
MOZART REAL ESTATE HOLDINGS, LP
By: MOZART GP, LLC
Its: General Partner
By:  

/s/ Alexander M. Liberman

  Name:   Alexander M. Liberman
  Title:   Chief Legal Officer and Secretary
Jurisdiction of Formation: Delaware
Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093


MOZART REAL ESTATE, LP
By: MOZART GP, LLC
Its: General Partner
By:  

/s/ Alexander M. Liberman

Name:   Alexander M. Liberman
Title:   Chief Legal Officer and Secretary
Jurisdiction of Formation: Delaware
Chief Executive Office: 3 Lakes Dr, Northfield, IL, 60093


BANK OF AMERICA, N.A., as Collateral Agent
By:  

/s/ David J. Smith

  Name:   David J. Smith
  Title:   Vice President
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer